|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.44/-0.08
|
企业价值
1.79B
|
资产负债 |
每股账面净值
4.34
|
现金流量 |
现金流量率
--
|
损益表 |
收益
627.12M
|
每股收益
0.84
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/26 03:23 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |